Barclays’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1
| Closed | – | – | 5027 |
|
|
2025
Q4 | $0 | Sell |
1
-5,264
| -100% | -$3.35K | ﹤0.01% | 5223 |
|
|
2025
Q3 | $3.19K | Sell |
5,265
-5,838
| -53% | -$2.75K | ﹤0.01% | 5120 |
|
|
2025
Q2 | $3.45K | Sell |
11,103
-117,981
| -91% | -$45.6K | ﹤0.01% | 5001 |
|
|
2025
Q1 | $63.1K | Sell |
129,084
-42,931
| -25% | -$25.3K | ﹤0.01% | 4559 |
|
|
2024
Q4 | $147K | Sell |
172,015
-27,997
| -14% | -$175K | ﹤0.01% | 4450 |
|
|
2024
Q3 | $1.7M | Buy |
200,012
+130,102
| +186% | +$767K | ﹤0.01% | 2985 |
|
|
2024
Q2 | $326K | Buy |
69,910
+8,638
| +14% | +$40.9K | ﹤0.01% | 3300 |
|
|
2024
Q1 | $417K | Buy |
+61,272
| New | +$275K | ﹤0.01% | 3701 |
|
|
2023
Q3 | – | Sell |
-232
| Closed | -$297 | – | 4591 |
|
|
2023
Q2 | $297 | Buy |
232
+221
| +2,009% | +$293 | ﹤0.01% | 4406 |
|
|
2023
Q1 | $9 | Buy |
+11
| New | +$11 | ﹤0.01% | 5034 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 4771 |
|
|
2022
Q2 | $0 | Sell |
1
-3,987
| -100% | -$6.53K | ﹤0.01% | 5005 |
|
|
2022
Q1 | $8K | Sell |
3,988
-17,510
| -81% | -$46.9K | ﹤0.01% | 4625 |
|
|
2021
Q4 | $193K | Buy |
21,498
+3,582
| +20% | +$47K | ﹤0.01% | 3579 |
|
|
2021
Q3 | $298K | Buy |
17,916
+15,586
| +669% | +$269K | ﹤0.01% | 3423 |
|
|
2021
Q2 | $49K | Sell |
2,330
-10,725
| -82% | -$203K | ﹤0.01% | 4138 |
|
|
2021
Q1 | $244K | Buy |
13,055
+8,658
| +197% | +$187K | ﹤0.01% | 3614 |
|
|
2020
Q4 | $97K | Sell |
4,397
-1,839
| -29% | -$38.3K | ﹤0.01% | 4146 |
|
|
2020
Q3 | $129K | Sell |
6,236
-9,887
| -61% | -$257K | ﹤0.01% | 4100 |
|
|
2020
Q2 | $584K | Sell |
16,123
-8,650
| -35% | -$362K | ﹤0.01% | 3215 |
|
|
2020
Q1 | $810K | Buy |
24,773
+3,308
| +15% | +$134K | ﹤0.01% | 3168 |
|
|
2019
Q4 | $586K | Buy |
21,465
+20,470
| +2,057% | +$351K | ﹤0.01% | 4158 |
|
|
2019
Q3 | $11K | Buy |
+995
| New | +$9.39K | ﹤0.01% | 6328 |
|
Barclays's APLT Position: Q1 2026 in Review
Barclays sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 1 share.
Barclays first reported a position in APLT in Q3 2019 and held it in 22 quarters. The position peaked at $1.7M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Barclays reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Barclays sold 1 Applied Therapeutics share in Q1 2026.
- Barclays first reported a position in Applied Therapeutics in Q3 2019 and held it in 22 quarters.
- Barclays's Applied Therapeutics position peaked at $1.7M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.